Interest of Flow Cytometry for the Diagnosis, the Follow up and Specific Immunotherapy (SIT) Arrest of Hymenoptera Venom Allergy
NCT00805402 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75
Last updated 2025-07-16
Summary
The aim of this study is to show that flow cytometry can be an accurate tool to help physicians regarding the diagnosis, the SIT decision and the SIT arrest of hymenoptera venom allergy.
75 patients having a story of reaction to hymenoptera venom will be selected for this trial.
Blood samples will be analyzed at: inclusion visit, Week 1 visit, Week 3 visit, Week 10 and Week 21 visit.
Conditions
- Allergy
Interventions
- OTHER
-
flow cytometry
flow cytometry
Sponsors & Collaborators
-
University Hospital, Limoges
lead OTHER
Principal Investigators
-
Michel COGNE, MD · CHU Limoges
-
Jean Sainte-Laudy, PhD · CHU Limoges
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-07-31
- Primary Completion
- 2010-07-31
- Completion
- 2010-07-31
Countries
- France
Study Locations
More Related Trials
-
Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSU
NCT02477332 ·Status: COMPLETED ·Phase: PHASE2
-
EoE Food Test Pilot Study
NCT07023380 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis
NCT00635089 ·Status: COMPLETED ·Phase: PHASE3
-
Short Duration 6Fed Sponge For EoE Patients
NCT03354221 ·Status: WITHDRAWN ·Phase: NA
-
Safety and Efficacy Study of Flebogamma 5% DIF IGIV in Pediatric Subjects
NCT00634569 ·Status: COMPLETED ·Phase: PHASE4
-
Esophageal String Test Monitoring to Monitor Eosinophilic Esophagitis During Oral Immunotherapy
NCT06389994 ·Status: RECRUITING
-
Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia
NCT00001406 ·Status: RECRUITING
-
A Study to Determine the Immunogenicity and Oral Tolerance to Keyhole Limpet Hemocyanin (KLH)
NCT01489956 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
An Open-label Extension Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis
NCT06435312 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
Cytosponge and Dietary Therapy in EoE
NCT02599558 ·Status: COMPLETED ·Phase: NA
-
Data and Sample Collection Study to Elucidate the Mechanisms of Eosinophilic Disorders
NCT00267501 ·Status: RECRUITING
-
Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years
NCT00538434 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS.
NCT07228390 ·Status: RECRUITING ·Phase: PHASE2
-
Omalizumab With Oral Food Immunotherapy With Food Allergies Open Label Safety Study in a Single Center
NCT01510626 ·Status: COMPLETED ·Phase: PHASE1
-
Real-life Study of How to Intensify Treatment With Xolair (OMALIZUMAB) in Chronic Spontaneous Urticaria
NCT04583475 ·Status: COMPLETED
-
Comparison of Immune Response in Normal Volunteers and Patients With Helminth Infections
NCT00004996 ·Status: COMPLETED
-
A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.
NCT07219615 ·Status: RECRUITING ·Phase: PHASE2
-
Urticaria Facticia Treatment With Omalizumab (UFO)
NCT02169115 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial
NCT00580606 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Low-dose IL-2 to the Kinetics of Regulatory T-cell in Healthy Volunteers
NCT03837093 ·Status: COMPLETED ·Phase: PHASE1
-
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
NCT00244686 ·Status: NO_LONGER_AVAILABLE
-
Gastrointestinal STRING Test With Oral Immunotherapy
NCT04943744 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Anti-Interleukin-5 Antibody to Treat Hypereosinophilic Syndrome
NCT00017862 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Subjects With IgE >= 30 IU/mL
NCT01544348 ·Status: COMPLETED ·Phase: PHASE1
-
Interleukin-2 for Refractory Chronic Spontaneous Urticaria
NCT06924762 ·Status: RECRUITING ·Phase: PHASE2/PHASE3